World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: PACTR
Last refreshed on: 29 April 2013
Main ID:  PACTR201007000226131
Date of registration: 20/06/2010
Primary sponsor: Dr, Habib A. G.
Public title: COMPARISM BETWEEN ONCE DAILY AND TWICE DAILY LPV/RTR CO-ADMINISTERED WITH TENOFOVIR AND EMTRICITOBIN AMONG HIV INFECTED PATIENTS DURING MUSLIM RAMADAN
Scientific title: COMPARISM BETWEEN ONCE DAILY AND TWICE DAILY LPV/RTR CO-ADMINISTERED WITH TENOFOVIR AND EMTRICITOBIN AMONG HIV INFECTED PATIENTS DURING MUSLIM RAMADAN FASTING.
Date of first enrolment: 2010-07-20
Target sample size: 100
Recruitment status: Not yet recruiting
URL:  HTTP://www.pactr.org/ATMWeb/appmanager/atm/atmregistry?da=true&tno=PACTR201007000226131
Study type:  interventional
Study design:  Parallel: different groups receive different interventions at same time during study,
Randomised,
simple randomisation using a randomisation table from a statistic book.,
Allocation was determined by the holder of the sequence who is situated off site,
 
Countries of recruitment
South Africa
Contacts
Name: AM  Yakasai
Address:  Dept. of Medicine AKTH, Kano 234 Kano Nigeria
Telephone: +2348065419097
Email: amyakasai@yahoo.com
Affiliation:  Senior registrar Infectious and Tropical Diseases
Name: Muhammad  Hamza
Address:  Dept. of Medicine AKTH, Kano 234 Kano Nigeria
Telephone: +2348035053139
Email: drhamza1020@ymail.com
Affiliation:  Senior registrar Infectious and Tropical Diseases
Key inclusion & exclusion criteria
Inclusion criteria: -age above 18 years
- clinically stable
-patint should be on Tenofovir + Emtricytobin+ Lopinavir/ritonavir.
-patient that consented.

Exclusion criteria: -Less than 18 year
-patient on other ARV regimen
-patient that refuse to consent.


Age minimum: 18 Year
Age maximum: 70 Year
Gender: Both
Health Condition(s) or Problem(s) studied

HIV/AIDS
null
Intervention(s)
Primary Outcome(s)
Adherence
Laboratory monitoring(Lipid profile, Kidney function test, haematocrit)
Therapeutic drug monitoring
Tolerability(Presence or Abscence of adverse drug effects)
Secondary Outcome(s)
Effectiveness(Viral load, CD4 count)
Secondary ID(s)
Source(s) of Monetary Support
Institute of human virology, Kano region -Nigeria
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history